nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Abacavir—acquired immunodeficiency syndrome	0.525	1	CrCtD
Nelarabine—DCK—Lamivudine—acquired immunodeficiency syndrome	0.13	1	CbGbCtD
Nelarabine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.114	0.487	CrCrCtD
Nelarabine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.063	0.269	CrCrCtD
Nelarabine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.057	0.244	CrCrCtD
Nelarabine—DGUOK—retina—acquired immunodeficiency syndrome	0.00168	0.0613	CbGeAlD
Nelarabine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.00149	1	CrCbGaD
Nelarabine—DGUOK—lymphoid tissue—acquired immunodeficiency syndrome	0.00119	0.0436	CbGeAlD
Nelarabine—DGUOK—digestive system—acquired immunodeficiency syndrome	0.00118	0.0431	CbGeAlD
Nelarabine—DGUOK—blood—acquired immunodeficiency syndrome	0.00112	0.041	CbGeAlD
Nelarabine—DGUOK—bone marrow—acquired immunodeficiency syndrome	0.00109	0.0397	CbGeAlD
Nelarabine—DGUOK—spinal cord—acquired immunodeficiency syndrome	0.00108	0.0395	CbGeAlD
Nelarabine—DGUOK—vagina—acquired immunodeficiency syndrome	0.00104	0.038	CbGeAlD
Nelarabine—POLA1—retina—acquired immunodeficiency syndrome	0.00103	0.0378	CbGeAlD
Nelarabine—DGUOK—lung—acquired immunodeficiency syndrome	0.000984	0.036	CbGeAlD
Nelarabine—DGUOK—nervous system—acquired immunodeficiency syndrome	0.000911	0.0333	CbGeAlD
Nelarabine—DGUOK—central nervous system—acquired immunodeficiency syndrome	0.000877	0.0321	CbGeAlD
Nelarabine—DGUOK—brain—acquired immunodeficiency syndrome	0.000696	0.0255	CbGeAlD
Nelarabine—POLA1—blood—acquired immunodeficiency syndrome	0.000692	0.0253	CbGeAlD
Nelarabine—ADA—lymphoid tissue—acquired immunodeficiency syndrome	0.000682	0.0249	CbGeAlD
Nelarabine—ADA—digestive system—acquired immunodeficiency syndrome	0.000674	0.0246	CbGeAlD
Nelarabine—DGUOK—lymph node—acquired immunodeficiency syndrome	0.000673	0.0246	CbGeAlD
Nelarabine—POLA1—bone marrow—acquired immunodeficiency syndrome	0.00067	0.0245	CbGeAlD
Nelarabine—ADA—blood—acquired immunodeficiency syndrome	0.000642	0.0235	CbGeAlD
Nelarabine—POLA1—vagina—acquired immunodeficiency syndrome	0.000642	0.0235	CbGeAlD
Nelarabine—DCK—retina—acquired immunodeficiency syndrome	0.000638	0.0233	CbGeAlD
Nelarabine—ADA—bone marrow—acquired immunodeficiency syndrome	0.000621	0.0227	CbGeAlD
Nelarabine—POLA1—lung—acquired immunodeficiency syndrome	0.000607	0.0222	CbGeAlD
Nelarabine—ADA—vagina—acquired immunodeficiency syndrome	0.000595	0.0218	CbGeAlD
Nelarabine—ADA—lung—acquired immunodeficiency syndrome	0.000563	0.0206	CbGeAlD
Nelarabine—ADA—nervous system—acquired immunodeficiency syndrome	0.000521	0.0191	CbGeAlD
Nelarabine—ADA—central nervous system—acquired immunodeficiency syndrome	0.000502	0.0183	CbGeAlD
Nelarabine—DCK—lymphoid tissue—acquired immunodeficiency syndrome	0.000453	0.0166	CbGeAlD
Nelarabine—DCK—digestive system—acquired immunodeficiency syndrome	0.000448	0.0164	CbGeAlD
Nelarabine—POLA1—brain—acquired immunodeficiency syndrome	0.000429	0.0157	CbGeAlD
Nelarabine—DCK—blood—acquired immunodeficiency syndrome	0.000427	0.0156	CbGeAlD
Nelarabine—POLA1—lymph node—acquired immunodeficiency syndrome	0.000415	0.0152	CbGeAlD
Nelarabine—DCK—bone marrow—acquired immunodeficiency syndrome	0.000413	0.0151	CbGeAlD
Nelarabine—DCK—spinal cord—acquired immunodeficiency syndrome	0.000411	0.015	CbGeAlD
Nelarabine—ADA—brain—acquired immunodeficiency syndrome	0.000398	0.0146	CbGeAlD
Nelarabine—DCK—vagina—acquired immunodeficiency syndrome	0.000396	0.0145	CbGeAlD
Nelarabine—ADA—lymph node—acquired immunodeficiency syndrome	0.000385	0.0141	CbGeAlD
Nelarabine—DCK—lung—acquired immunodeficiency syndrome	0.000374	0.0137	CbGeAlD
Nelarabine—DCK—nervous system—acquired immunodeficiency syndrome	0.000346	0.0127	CbGeAlD
Nelarabine—DCK—central nervous system—acquired immunodeficiency syndrome	0.000334	0.0122	CbGeAlD
Nelarabine—DCK—brain—acquired immunodeficiency syndrome	0.000265	0.00968	CbGeAlD
Nelarabine—DCK—lymph node—acquired immunodeficiency syndrome	0.000256	0.00935	CbGeAlD
Nelarabine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	6.62e-05	0.000803	CcSEcCtD
Nelarabine—Myalgia—Efavirenz—acquired immunodeficiency syndrome	6.62e-05	0.000803	CcSEcCtD
Nelarabine—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	6.59e-05	0.000799	CcSEcCtD
Nelarabine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	6.59e-05	0.000799	CcSEcCtD
Nelarabine—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	6.59e-05	0.000799	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	6.58e-05	0.000798	CcSEcCtD
Nelarabine—Headache—Amprenavir—acquired immunodeficiency syndrome	6.58e-05	0.000798	CcSEcCtD
Nelarabine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	6.58e-05	0.000798	CcSEcCtD
Nelarabine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	6.57e-05	0.000797	CcSEcCtD
Nelarabine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	6.57e-05	0.000797	CcSEcCtD
Nelarabine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	6.55e-05	0.000794	CcSEcCtD
Nelarabine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000793	CcSEcCtD
Nelarabine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	6.54e-05	0.000793	CcSEcCtD
Nelarabine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	6.54e-05	0.000792	CcSEcCtD
Nelarabine—Chills—Lamivudine—acquired immunodeficiency syndrome	6.51e-05	0.00079	CcSEcCtD
Nelarabine—Cough—Delavirdine—acquired immunodeficiency syndrome	6.5e-05	0.000787	CcSEcCtD
Nelarabine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	6.49e-05	0.000787	CcSEcCtD
Nelarabine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.000786	CcSEcCtD
Nelarabine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.000786	CcSEcCtD
Nelarabine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	6.47e-05	0.000785	CcSEcCtD
Nelarabine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	6.47e-05	0.000785	CcSEcCtD
Nelarabine—Tremor—Ritonavir—acquired immunodeficiency syndrome	6.45e-05	0.000782	CcSEcCtD
Nelarabine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	6.44e-05	0.000781	CcSEcCtD
Nelarabine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	6.42e-05	0.000779	CcSEcCtD
Nelarabine—Back pain—Saquinavir—acquired immunodeficiency syndrome	6.41e-05	0.000777	CcSEcCtD
Nelarabine—Anorexia—Indinavir—acquired immunodeficiency syndrome	6.41e-05	0.000776	CcSEcCtD
Nelarabine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	6.4e-05	0.000776	CcSEcCtD
Nelarabine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.000771	CcSEcCtD
Nelarabine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	6.34e-05	0.000768	CcSEcCtD
Nelarabine—Myalgia—Delavirdine—acquired immunodeficiency syndrome	6.34e-05	0.000768	CcSEcCtD
Nelarabine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	6.34e-05	0.000768	CcSEcCtD
Nelarabine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	6.32e-05	0.000766	CcSEcCtD
Nelarabine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	6.28e-05	0.000761	CcSEcCtD
Nelarabine—Nausea—Amprenavir—acquired immunodeficiency syndrome	6.24e-05	0.000756	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	6.24e-05	0.000756	CcSEcCtD
Nelarabine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	6.23e-05	0.000755	CcSEcCtD
Nelarabine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	6.23e-05	0.000755	CcSEcCtD
Nelarabine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	6.22e-05	0.000754	CcSEcCtD
Nelarabine—Tremor—Saquinavir—acquired immunodeficiency syndrome	6.21e-05	0.000752	CcSEcCtD
Nelarabine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.00075	CcSEcCtD
Nelarabine—Pain—Zidovudine—acquired immunodeficiency syndrome	6.18e-05	0.000749	CcSEcCtD
Nelarabine—Constipation—Zidovudine—acquired immunodeficiency syndrome	6.18e-05	0.000749	CcSEcCtD
Nelarabine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	6.18e-05	0.000749	CcSEcCtD
Nelarabine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	6.16e-05	0.000747	CcSEcCtD
Nelarabine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.000743	CcSEcCtD
Nelarabine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	6.12e-05	0.000742	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	6.12e-05	0.000742	CcSEcCtD
Nelarabine—Back pain—Lamivudine—acquired immunodeficiency syndrome	6.11e-05	0.000741	CcSEcCtD
Nelarabine—Vomiting—Didanosine—acquired immunodeficiency syndrome	6.09e-05	0.000738	CcSEcCtD
Nelarabine—Insomnia—Indinavir—acquired immunodeficiency syndrome	6.08e-05	0.000737	CcSEcCtD
Nelarabine—Oedema—Delavirdine—acquired immunodeficiency syndrome	6.08e-05	0.000736	CcSEcCtD
Nelarabine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	6.05e-05	0.000734	CcSEcCtD
Nelarabine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	6.05e-05	0.000733	CcSEcCtD
Nelarabine—Infection—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.000732	CcSEcCtD
Nelarabine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	6.03e-05	0.000731	CcSEcCtD
Nelarabine—Cough—Ritonavir—acquired immunodeficiency syndrome	6.01e-05	0.000728	CcSEcCtD
Nelarabine—Headache—Didanosine—acquired immunodeficiency syndrome	6e-05	0.000727	CcSEcCtD
Nelarabine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	5.99e-05	0.000726	CcSEcCtD
Nelarabine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	5.98e-05	0.000725	CcSEcCtD
Nelarabine—Somnolence—Indinavir—acquired immunodeficiency syndrome	5.97e-05	0.000724	CcSEcCtD
Nelarabine—Asthenia—Stavudine—acquired immunodeficiency syndrome	5.96e-05	0.000723	CcSEcCtD
Nelarabine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	5.96e-05	0.000723	CcSEcCtD
Nelarabine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	5.95e-05	0.000722	CcSEcCtD
Nelarabine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	5.95e-05	0.000721	CcSEcCtD
Nelarabine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	5.93e-05	0.000719	CcSEcCtD
Nelarabine—Tremor—Lamivudine—acquired immunodeficiency syndrome	5.92e-05	0.000718	CcSEcCtD
Nelarabine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	5.91e-05	0.000716	CcSEcCtD
Nelarabine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	5.89e-05	0.000714	CcSEcCtD
Nelarabine—Asthenia—Abacavir—acquired immunodeficiency syndrome	5.88e-05	0.000712	CcSEcCtD
Nelarabine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.00071	CcSEcCtD
Nelarabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.00071	CcSEcCtD
Nelarabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.00071	CcSEcCtD
Nelarabine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	5.84e-05	0.000708	CcSEcCtD
Nelarabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000708	CcSEcCtD
Nelarabine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	5.82e-05	0.000706	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	5.8e-05	0.000703	CcSEcCtD
Nelarabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	5.79e-05	0.000702	CcSEcCtD
Nelarabine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	5.79e-05	0.000702	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	5.78e-05	0.000701	CcSEcCtD
Nelarabine—Cough—Saquinavir—acquired immunodeficiency syndrome	5.78e-05	0.000701	CcSEcCtD
Nelarabine—Pain—Indinavir—acquired immunodeficiency syndrome	5.75e-05	0.000697	CcSEcCtD
Nelarabine—Constipation—Indinavir—acquired immunodeficiency syndrome	5.75e-05	0.000697	CcSEcCtD
Nelarabine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	5.74e-05	0.000696	CcSEcCtD
Nelarabine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	5.74e-05	0.000696	CcSEcCtD
Nelarabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	5.71e-05	0.000692	CcSEcCtD
Nelarabine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	5.71e-05	0.000692	CcSEcCtD
Nelarabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	5.71e-05	0.000692	CcSEcCtD
Nelarabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	5.7e-05	0.000691	CcSEcCtD
Nelarabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	5.69e-05	0.00069	CcSEcCtD
Nelarabine—Nausea—Didanosine—acquired immunodeficiency syndrome	5.69e-05	0.000689	CcSEcCtD
Nelarabine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	5.68e-05	0.000688	CcSEcCtD
Nelarabine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000687	CcSEcCtD
Nelarabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	5.66e-05	0.000686	CcSEcCtD
Nelarabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	5.66e-05	0.000686	CcSEcCtD
Nelarabine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	5.64e-05	0.000684	CcSEcCtD
Nelarabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000684	CcSEcCtD
Nelarabine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000684	CcSEcCtD
Nelarabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000684	CcSEcCtD
Nelarabine—Oedema—Ritonavir—acquired immunodeficiency syndrome	5.62e-05	0.000681	CcSEcCtD
Nelarabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	5.6e-05	0.000679	CcSEcCtD
Nelarabine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	5.56e-05	0.000673	CcSEcCtD
Nelarabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	5.54e-05	0.000671	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	5.53e-05	0.000671	CcSEcCtD
Nelarabine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.000669	CcSEcCtD
Nelarabine—Cough—Lamivudine—acquired immunodeficiency syndrome	5.52e-05	0.000669	CcSEcCtD
Nelarabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	5.51e-05	0.000668	CcSEcCtD
Nelarabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	5.51e-05	0.000668	CcSEcCtD
Nelarabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	5.5e-05	0.000667	CcSEcCtD
Nelarabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	5.5e-05	0.000666	CcSEcCtD
Nelarabine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	5.5e-05	0.000666	CcSEcCtD
Nelarabine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	5.49e-05	0.000666	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	5.48e-05	0.000664	CcSEcCtD
Nelarabine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	5.48e-05	0.000664	CcSEcCtD
Nelarabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	5.47e-05	0.000664	CcSEcCtD
Nelarabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.000664	CcSEcCtD
Nelarabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	5.46e-05	0.000661	CcSEcCtD
Nelarabine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	5.45e-05	0.000661	CcSEcCtD
Nelarabine—Pain—Efavirenz—acquired immunodeficiency syndrome	5.43e-05	0.000658	CcSEcCtD
Nelarabine—Constipation—Efavirenz—acquired immunodeficiency syndrome	5.43e-05	0.000658	CcSEcCtD
Nelarabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	5.42e-05	0.000657	CcSEcCtD
Nelarabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	5.42e-05	0.000656	CcSEcCtD
Nelarabine—Oedema—Saquinavir—acquired immunodeficiency syndrome	5.41e-05	0.000655	CcSEcCtD
Nelarabine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	5.4e-05	0.000655	CcSEcCtD
Nelarabine—Headache—Nevirapine—acquired immunodeficiency syndrome	5.39e-05	0.000654	CcSEcCtD
Nelarabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000652	CcSEcCtD
Nelarabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000652	CcSEcCtD
Nelarabine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000652	CcSEcCtD
Nelarabine—Infection—Saquinavir—acquired immunodeficiency syndrome	5.37e-05	0.000651	CcSEcCtD
Nelarabine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	5.36e-05	0.000649	CcSEcCtD
Nelarabine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.31e-05	0.000644	CcSEcCtD
Nelarabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	5.31e-05	0.000644	CcSEcCtD
Nelarabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	5.3e-05	0.000643	CcSEcCtD
Nelarabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.3e-05	0.000643	CcSEcCtD
Nelarabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	5.29e-05	0.000642	CcSEcCtD
Nelarabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	5.29e-05	0.000641	CcSEcCtD
Nelarabine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	5.28e-05	0.00064	CcSEcCtD
Nelarabine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	5.25e-05	0.000636	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	5.24e-05	0.000636	CcSEcCtD
Nelarabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	5.24e-05	0.000635	CcSEcCtD
Nelarabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	5.23e-05	0.000634	CcSEcCtD
Nelarabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	5.22e-05	0.000633	CcSEcCtD
Nelarabine—Headache—Stavudine—acquired immunodeficiency syndrome	5.21e-05	0.000631	CcSEcCtD
Nelarabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	5.21e-05	0.000631	CcSEcCtD
Nelarabine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	5.2e-05	0.00063	CcSEcCtD
Nelarabine—Pain—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.00063	CcSEcCtD
Nelarabine—Constipation—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.00063	CcSEcCtD
Nelarabine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	5.19e-05	0.000629	CcSEcCtD
Nelarabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	5.18e-05	0.000628	CcSEcCtD
Nelarabine—Oedema—Lamivudine—acquired immunodeficiency syndrome	5.16e-05	0.000625	CcSEcCtD
Nelarabine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	5.15e-05	0.000625	CcSEcCtD
Nelarabine—Headache—Abacavir—acquired immunodeficiency syndrome	5.13e-05	0.000622	CcSEcCtD
Nelarabine—Infection—Lamivudine—acquired immunodeficiency syndrome	5.12e-05	0.000621	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.12e-05	0.00062	CcSEcCtD
Nelarabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.11e-05	0.00062	CcSEcCtD
Nelarabine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.08e-05	0.000616	CcSEcCtD
Nelarabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.06e-05	0.000613	CcSEcCtD
Nelarabine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.05e-05	0.000612	CcSEcCtD
Nelarabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.05e-05	0.000612	CcSEcCtD
Nelarabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.04e-05	0.000611	CcSEcCtD
Nelarabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.02e-05	0.000608	CcSEcCtD
Nelarabine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.02e-05	0.000608	CcSEcCtD
Nelarabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.01e-05	0.000607	CcSEcCtD
Nelarabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.01e-05	0.000607	CcSEcCtD
Nelarabine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	4.99e-05	0.000605	CcSEcCtD
Nelarabine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	4.97e-05	0.000602	CcSEcCtD
Nelarabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.95e-05	0.0006	CcSEcCtD
Nelarabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	4.94e-05	0.000599	CcSEcCtD
Nelarabine—Nausea—Stavudine—acquired immunodeficiency syndrome	4.94e-05	0.000599	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	4.93e-05	0.000597	CcSEcCtD
Nelarabine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.000596	CcSEcCtD
Nelarabine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	4.89e-05	0.000593	CcSEcCtD
Nelarabine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	4.88e-05	0.000592	CcSEcCtD
Nelarabine—Nausea—Abacavir—acquired immunodeficiency syndrome	4.86e-05	0.00059	CcSEcCtD
Nelarabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	4.86e-05	0.000589	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	4.85e-05	0.000588	CcSEcCtD
Nelarabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000587	CcSEcCtD
Nelarabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	4.82e-05	0.000584	CcSEcCtD
Nelarabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	4.82e-05	0.000584	CcSEcCtD
Nelarabine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	4.82e-05	0.000584	CcSEcCtD
Nelarabine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	4.81e-05	0.000583	CcSEcCtD
Nelarabine—Pain—Ritonavir—acquired immunodeficiency syndrome	4.8e-05	0.000582	CcSEcCtD
Nelarabine—Constipation—Ritonavir—acquired immunodeficiency syndrome	4.8e-05	0.000582	CcSEcCtD
Nelarabine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	4.8e-05	0.000582	CcSEcCtD
Nelarabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	4.8e-05	0.000582	CcSEcCtD
Nelarabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	4.78e-05	0.000579	CcSEcCtD
Nelarabine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.00057	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.7e-05	0.00057	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.67e-05	0.000566	CcSEcCtD
Nelarabine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.67e-05	0.000566	CcSEcCtD
Nelarabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.000565	CcSEcCtD
Nelarabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.63e-05	0.000561	CcSEcCtD
Nelarabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.63e-05	0.000561	CcSEcCtD
Nelarabine—Pain—Saquinavir—acquired immunodeficiency syndrome	4.62e-05	0.00056	CcSEcCtD
Nelarabine—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.62e-05	0.00056	CcSEcCtD
Nelarabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.6e-05	0.000557	CcSEcCtD
Nelarabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.6e-05	0.000557	CcSEcCtD
Nelarabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.59e-05	0.000557	CcSEcCtD
Nelarabine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.59e-05	0.000557	CcSEcCtD
Nelarabine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.59e-05	0.000556	CcSEcCtD
Nelarabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.56e-05	0.000552	CcSEcCtD
Nelarabine—Headache—Zidovudine—acquired immunodeficiency syndrome	4.53e-05	0.000549	CcSEcCtD
Nelarabine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	4.48e-05	0.000544	CcSEcCtD
Nelarabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	4.46e-05	0.00054	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	4.45e-05	0.00054	CcSEcCtD
Nelarabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.45e-05	0.000539	CcSEcCtD
Nelarabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.44e-05	0.000539	CcSEcCtD
Nelarabine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.44e-05	0.000538	CcSEcCtD
Nelarabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	4.44e-05	0.000538	CcSEcCtD
Nelarabine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.42e-05	0.000536	CcSEcCtD
Nelarabine—Pain—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000535	CcSEcCtD
Nelarabine—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.41e-05	0.000535	CcSEcCtD
Nelarabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.36e-05	0.000528	CcSEcCtD
Nelarabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.34e-05	0.000527	CcSEcCtD
Nelarabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.29e-05	0.00052	CcSEcCtD
Nelarabine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.27e-05	0.000518	CcSEcCtD
Nelarabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.27e-05	0.000518	CcSEcCtD
Nelarabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.27e-05	0.000518	CcSEcCtD
Nelarabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.25e-05	0.000515	CcSEcCtD
Nelarabine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.22e-05	0.000511	CcSEcCtD
Nelarabine—Headache—Indinavir—acquired immunodeficiency syndrome	4.21e-05	0.00051	CcSEcCtD
Nelarabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.2e-05	0.000509	CcSEcCtD
Nelarabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.16e-05	0.000504	CcSEcCtD
Nelarabine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.08e-05	0.000494	CcSEcCtD
Nelarabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.08e-05	0.000494	CcSEcCtD
Nelarabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.04e-05	0.000489	CcSEcCtD
Nelarabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.03e-05	0.000489	CcSEcCtD
Nelarabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.02e-05	0.000487	CcSEcCtD
Nelarabine—Nausea—Indinavir—acquired immunodeficiency syndrome	3.99e-05	0.000484	CcSEcCtD
Nelarabine—Headache—Efavirenz—acquired immunodeficiency syndrome	3.98e-05	0.000482	CcSEcCtD
Nelarabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	3.88e-05	0.00047	CcSEcCtD
Nelarabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	3.86e-05	0.000468	CcSEcCtD
Nelarabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	3.84e-05	0.000466	CcSEcCtD
Nelarabine—Headache—Delavirdine—acquired immunodeficiency syndrome	3.81e-05	0.000461	CcSEcCtD
Nelarabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.77e-05	0.000457	CcSEcCtD
Nelarabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.71e-05	0.00045	CcSEcCtD
Nelarabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.7e-05	0.000449	CcSEcCtD
Nelarabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.7e-05	0.000448	CcSEcCtD
Nelarabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.61e-05	0.000437	CcSEcCtD
Nelarabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.58e-05	0.000433	CcSEcCtD
Nelarabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.57e-05	0.000433	CcSEcCtD
Nelarabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.53e-05	0.000428	CcSEcCtD
Nelarabine—Headache—Ritonavir—acquired immunodeficiency syndrome	3.52e-05	0.000427	CcSEcCtD
Nelarabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.44e-05	0.000417	CcSEcCtD
Nelarabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.41e-05	0.000413	CcSEcCtD
Nelarabine—Headache—Saquinavir—acquired immunodeficiency syndrome	3.39e-05	0.000411	CcSEcCtD
Nelarabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.34e-05	0.000404	CcSEcCtD
Nelarabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.28e-05	0.000398	CcSEcCtD
Nelarabine—Headache—Lamivudine—acquired immunodeficiency syndrome	3.23e-05	0.000392	CcSEcCtD
Nelarabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.21e-05	0.000389	CcSEcCtD
Nelarabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.06e-05	0.000371	CcSEcCtD
